R 102557
Latest Information Update: 15 Dec 2003
At a glance
- Originator Sankyo
- Class Antifungals
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 15 Dec 2003 No development reported - Preclinical for Mycoses in USA (unspecified route)
- 26 Sep 2000 New profile
- 26 Sep 2000 Preclinical development for Mycoses in USA (Unknown route)